You can find the annual or quarterly income statement of Curanex Pharmaceuticals Inc here for insights into the performance and operational efficiency of Curanex Pharmaceuticals Inc.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

Operating expenses

--951.33K

--57.66K

R&D expenses

--677.47K

----

Operating profit

---951.33K

---57.66K

Net non-operating interest income (expenses)

Non-operating interest expense

--4.09K

--3.09K

Other non-operating income (expenses)

--1.36K

--403.00

Income before tax

---954.06K

---60.35K

Income after tax

---954.06K

---60.35K

Net income from continuous operations

---954.06K

---60.35K

Net income attributable to controlling interests

---954.06K

---60.35K

Net income attributable to common shareholders

---954.06K

---60.35K

Basic earnings per share

---0.04

--0.00

Diluted earnings per share

---0.04

--0.00

Dividend per share

--0.00

Currency unit

USD

Audit opinions

FAQs

What is the income statement?



The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.

KeyAI

